Compugen (CGEN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CGEN Compugen

Watchlist

1.8050
+0.0550+3.14%

Close Sep 27 16:00 ET

1.8200
+0.0150+0.83%

Post 17:35 ET

161.61MMarket Cap-18050P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

GSK, ITeos Lung Cancer Therapy Outperforms Jemperli in Mid-stage Trial
Seeking AlphaSep 14 07:16 ET
Compugen Shareholders Approve All Proposals
TipRanksSep 13 07:27 ET
Compugen to Present at Single Cell Genomics 2024 Conference
Yahoo FinanceSep 9 07:00 ET
This Is Why Compugen Ltd.'s (NASDAQ:CGEN) CEO Compensation Looks Appropriate
Simply Wall StSep 6 06:43 ET
Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PR NewswireAug 29 07:00 ET
Can Compugen (CGEN) Run Higher on Rising Earnings Estimates?
Zacks Aug 26 11:25 ET

Comments

Tsukasa0_0

May 30 22:01

About to Receive Milestone Payment

$Compugen (CGEN.US)$ 🤩
Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig

Moomoo AI

Mar 8 05:18

The market anticipates a decline in future revenue, possibly explaining the suppressed P/S. This weak revenue outlook could continue to pressure shares, making it hard to maintain current prices. Shareholders accept the low P/S, expecting future revenue may not bring pleasant surprises.

Compugen Ltd. (NASDAQ:CGEN) Held Back By Insufficient Growth Even After Shares Climb 26%

FlexibleTrader

Mar 5 12:00

$Compugen (CGEN.US)$ fk entered very early! now no option to hold at lesast 2 week or more !

FlexibleTrader

Mar 4 18:23

$Compugen (CGEN.US)$ 👀looks good i n game 🎲

Moomoo AI

Feb 15 06:06

Michelle Mahler's appointment as Chief Medical Officer is a positive step for Compugen, thanks to her vast clinical development experience. Her leadership in the COM503 Phase 1 study and future role in advancing COM701, COM902, and COM503 are anticipated to significantly boost the company's clinical development strategy.

Press Release: Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

CGEN Compugen

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target